Dec 17, 2025
1:25
For every 25 shares held, investors received 1. The price per share adjusted from $0.12 to $3.00.
The split itself did not change the total investment value.
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) operates in the Pharmaceuticals: major industry.
Processa Pharmaceuticals, Inc. company overviewProcessa Pharmaceuticals, Inc.'s most recent stock split was on December 17, 2025. It was a 1-for-25 reverse split, so shareholders received 1 share for every 25 they held.
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) has split its stock 5 times: a 1-for-7 reverse split on December 8, 2017, a 1-for-7 reverse split on December 26, 2017, a 1-for-7 reverse split on December 24, 2019, a 1-for-20 reverse split on January 22, 2024, and a 1-for-25 reverse split on December 17, 2025.
Processa Pharmaceuticals, Inc. has split its stock 5 times. This history records 5 reverse splits between December 8, 2017 and December 17, 2025.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Processa Pharmaceuticals, Inc.'s 1-for-25 reverse split on December 17, 2025, every 25 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Processa Pharmaceuticals, Inc. has not announced a new split in our records. Its most recent split was on December 17, 2025, less than a year ago. Companies announce splits in advance, and any new NASDAQ:PCSA split will appear on this page.